Trials / Withdrawn
WithdrawnNCT02399852
Effects of Lomitapide on Carotid and Aortic Atherosclerosis
Effects of Lomitapide on Carotid and Aortic Atherosclerosis in Patients Treated With Lomitapide in Usual Care (CAPTURE)
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Aegerion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to assess changes in carotid and aortic atherosclerosis in patients being treated with lomitapide.
Detailed description
This is a multi-center long-term open-label non-comparative study to assess changes in carotid and aortic atherosclerosis in patients being treated with lomitapide. Patients from countries in the EU, the US and Canada who are being treated with lomitapide and are enrolled in The Lomitapide Observational Worldwide Evaluation Registry (LOWER), will be invited by the LOWER enrolling physician to participate in this substudy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lomitapide |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2018-12-01
- Completion
- 2021-12-01
- First posted
- 2015-03-26
- Last updated
- 2017-12-15
Source: ClinicalTrials.gov record NCT02399852. Inclusion in this directory is not an endorsement.